Evans Daron

CIK 00014117263 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001411726

Recent Transactions

50 trades

Purchase
Rezolute, Inc.$RZLT
Common Shares
2025-12-09$5.04/sh+10,549→ 131,900 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-11-19+107,000→ 375,900 total
Award
Rezolute, Inc.$RZLT
Employee Stock Option (Right to Buy)
2025-11-19+63,000→ 63,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2025-06-24$4.05/sh+5,000→ 268,900 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-06-10+26,000→ 263,900 total
Award
Rezolute, Inc.$RZLT
Employee Stock Option (Right to Buy)
2025-06-10+15,000→ 15,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2025-03-26$2.89/sh+10,000→ 237,900 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2025-03-26$2.88/sh+10,000→ 23,000 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-02-16+77,000→ 227,900 total
Award
Rezolute, Inc.$RZLT
Employee Stock Option (Right to Buy)
2025-02-16+45,000→ 45,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-12-18$4.29/sh+10,000→ 150,900 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-12-12$4.60/sh+9,000→ 140,900 total
Award
Rezolute, Inc.$RZLT
Employee Stock Option (Right to Buy)
2024-09-23+100,000→ 100,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-06-14$4.04/sh+40,000→ 40,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-05-29$3.50/sh+451→ 121,351 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-05-24$3.23/sh+2,942→ 13,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-05-23$2.85/sh+58→ 10,058 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-03-15$1.69/sh+20,000→ 20,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-03-08$1.93/sh+50,000→ 120,900 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-02-16$1.30/sh+41,900→ 70,900 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-02-16$1.37/sh+4,500→ 4,500 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2024-02-16$1.37/sh+4,500→ 4,500 total
Award
Rezolute, Inc.$RZLT
Employee Stock Option (Right to Buy)
2024-01-23+275,000→ 275,000 total
Tax Payment
NEPHROS INC$NEPH
Common Stock
2021-05-27$2.70/sh−349→ 8,947 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock Warrants (Right to Buy)
2021-05-24−1,111→ 0 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock
2021-05-24$2.70/sh+1,111→ 9,018 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock Warrants (Right to Buy)
2021-05-24−1,111→ 0 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock
2021-05-24$2.70/sh+1,111→ 9,296 total
Purchase
NEPHROS INC$NEPH
Common Stock
2020-03-12$6.65/sh+2,500→ 134,215 total
Purchase
NEPHROS INC$NEPH
Common Stock
2020-03-05$8.44/sh+2,500→ 131,715 total
Award
NEPHROS INC$NEPH
Stock Option (Right to Buy)
2020-02-01+97,076→ 242,690 total
Award
NEPHROS INC$NEPH
Stock Option (Right to Buy)
2019-12-16+20,000→ 20,000 total
Award
NEPHROS INC$NEPH
Common Stock
2019-12-16+9,282→ 129,215 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-11-18$8.35/sh+1,000→ 119,933 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-08-22$6.92/sh+2,000→ 118,933 total
Award
NEPHROS INC$NEPH
Stock Option (Right to Buy)
2019-08-09+36,404→ 145,614 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-06-14$0.59/sh+8,000→ 71,166 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-06-14$0.60/sh+8,000→ 8,000 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-06-14$0.61/sh+8,000→ 8,000 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-06-14$0.58/sh+8,000→ 73,666 total
Purchase
NEPHROS INC$NEPH
Common Stock
2019-06-14$0.60/sh+11,172→ 1,052,426 total
Award
NEPHROS INC$NEPH
Common Stock
2018-12-14+108,296→ 1,001,254 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock Warrants (Right to Buy)
2018-05-14−40,000→ 0 total
Exercise of In-Money
NEPHROS INC$NEPH
Common Stock
2018-05-14$0.30/sh+40,000→ 95,000 total
Purchase
NEPHROS INC$NEPH
Common Stock
2018-04-10$0.45/sh+12,000→ 63,166 total
Purchase
NEPHROS INC$NEPH
Common Stock
2018-04-10$0.45/sh+55,000→ 55,000 total
Purchase
NEPHROS INC$NEPH
Common Stock
2018-04-10$0.45/sh+12,000→ 65,666 total
Award
NEPHROS INC$NEPH
Stock Option (Right to Buy)
2018-02-01+218,419→ 982,887 total
Award
NEPHROS INC$NEPH
Common Stock
2017-12-20+180,000→ 892,958 total
Award
NEPHROS INC$NEPH
Stock Option (Right to Buy)
2017-12-20+837,125→ 837,125 total

Companies

Recent Filings

Address

C/O NILE THERAPEUTICS, INC. 115 SANSOME STREET, SUITE #310

SAN FRANCISCO, CA, 94104

View on SEC.gov